Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm [4]

British Journal of Ophthalmology

Volumn 86, Issue 9, 2002, Pages 1065-1066

  Fardin, B ^a   Weissgold, David J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; FLUTICASONE; STEROID;

ADULT; BRONCHOSPASM; CASE REPORT; CENTRAL SEROUS RETINOPATHY; COLOR VISION DEFECT; FEMALE; HUMAN; LETTER; MYCOPLASMA PNEUMONIA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; STEROID THERAPY; VISUAL ACUITY;

ADULT; ANDROSTADIENES; BRONCHIAL SPASM; BRONCHODILATOR AGENTS; CHOROID DISEASES; FEMALE; HUMANS; PARASYMPATHOLYTICS; PNEUMONIA, MYCOPLASMA; RETINAL DISEASES;

EID: 0036724567     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.9.1065     Document Type: Letter

References (7)

1. Retinal pigment epithelial changes associated with systemic corticosteroid treatment: Report of cases and review of the literature
2. Central serous chorioretinopathy complicating systemic corticosteroid treatment
3. Intraocular pressure elevation associated with inhalation and nasal corticosteroids
4. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids
5. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids
6. Central serous chorioretinopathy in endogenous hypercortisolism